期刊文献+

类风湿关节炎患者外周血单个核细胞表达人类白细胞抗原G的研究

Investigation of the peripheral blood mononuclear cells expressing HLA-G of patients with rheumatoid arthritis
原文传递
导出
摘要 目的探讨RA患者PBMCs上HLA-G的表达及其与RA疾病活动度、病程、临床用药及各实验室指标的相关关系。方法采用流式细胞术检测68例RA患者和63名健康对照者PBMCs中淋巴细胞、CD3+T细胞和CD14+单核细胞上HLA—G的表达。采用非参数Mann-Whitnev U检验、Speatinan等级相关分析。结果RA患者外周血HLA—G+淋巴细胞百分比显著低于健康对照组[1.98%(1.17%~3.66%与2.93%(1.70%-5.40%),U=1624.5,P〈0.05],而且HLA—G+淋巴细胞百分比与RA疾病活动度DAS28评分呈负相关(r=-0.288,P=0.017);CD3+HLA-G+T细胞百分比亦明显降低[1.35%(0.57%~2.79%)与2.16%(1.15%~4.45%),U=1387,P=-0.000],且与DAS28评分呈负相关(r—0.373,P=0.001);CDl=14+HLA—G+单核细胞百分比明显低于健康对照组[22.65%(10.59%~36.81%)与32.76%(20.73%~44.62%),U=I526,P〈0.01],但未发现CD14+HLA-G单细胞百分比与DAS28评分存在显著相关性(P〉O.05)。此外,上述各类细胞上HLA—G的表达与RA患者病程、临床用药及各实验室指标如RF、ESR、CRP、抗CCP抗体和ANA水平等均无显著相关性(均P〉0.05)。结论RA患者外周血淋巴细胞、CD3+T细胞和CD14+单核细胞上HLA.G的表达异常降低,HLA—G分子的异常降低可能导致机体免疫抑制功能低下,从而促进了RA的发生发展。 Objective To investigate the expression of HLA-G in lymphocytes, CD3+T cells, and CD14+ monocytes from patients with rheumatoid arthritis (RA) and their associations with disease activity, disease duration, medication used and clinical parameters. Methods We studied 68 RA patients as well as 63 healthy controls. HLA-G expression was analyzed by flow cytometry in peripheral blood mononuclear ceils (PBMCs). Mann Whitney U tests and Spearman rank correlation coefficient test were used for statistical analysis. Results We found that lymphocytes as well as CD3+T cells, and CD14+monocytes in RA patients showed a diminished expression of HLA-G compared with healthy controls [ 1.98%(1.17%-3.66%) vs 2.93% (1.70%-5.40%), U=1624.5, P〈0.05; 1.35%(0.57%-2.79%) vs 2.16% (1.15%-4.45%), U=1387, P=0.000; 22.65% (10.59%-36.81%) vs 32.76% (20.73%-44.62%), U=1526, P〈0.01 ]. Spearman analysis showed that the levels of HLA-G~ lymphocytes as well as CD3+ HLA-G~ T cells was negatively associated with DAS28 score(r=-0.288, P= 0.017; r=-0.373, P=0.001), but no significant correlation was detected between the levels of CD14~HLA-G+monocytes and DAS 28 score (/9〉0.05). In addition, the levels of expression of HLA-G was not correlated to disease duration, medication used, ESR, CRP, RF, anti-CCP and ANA (P〉0.05). Condttsion Decreased expression of HLA-G are detected in lymphocytes, CD3+ T cells, and CD14+ monocytes from pa-tients with RA, and the abnormality of HLA-G may play an important role in the development of RA.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2014年第5期325-328,共4页 Chinese Journal of Rheumatology
基金 浙江省自然科学基金(LY12H10002) 浙江省科技计划(2010C33001)
关键词 关节炎 类风湿 HLA抗原 疾病活动度 Arthritis, rheumatoid HLA antigens Disease activity
  • 相关文献

参考文献11

  • 1Yan WH.HLA-G expression in cancer:potential role in diagno sis,prognosis and therapy[J].Endocr Metab Immune Disord Drug Targets,2011,11:76-89.
  • 2Arnett FC,Edworthy SM,Bloch DA,et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis[J].Arthritis Rheum,1988,31:315-324.
  • 3Prevoo ML,Van't Hof MA,Kuper HH,et al.Modified disease activity scores that includes twenty-eight joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis[J].Arthritis Rheum,1995,38:44-48.
  • 4Pistoia V,Morandi F,Wang X,et al.Soluble HLA-G:are they clinically relevant?[J].Semin Cancer Biol,2007,17:469-479.
  • 5陈海凤,孙凌云.人类白细胞抗原-G免疫调节与自身免疫病研究进展[J].中华风湿病学杂志,2011,15(7):493-496. 被引量:2
  • 6Verbruggen LA,Rebmann V,Demanet C,et al.Soluble HLA-G in rheumatoid arthritis[J].Hum Immunol,2006,67:561-567.
  • 7Rizzo R,Farina I,Bortolotti D,et al.HLA-G may predict the disease course in patients with early rheumatoid arthritis[J].Hum Immunol,2013,74:425-432.
  • 8Mitsdoerffer M,Schreiner B,Kieseier BC,et al.Monocyte derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo:rationale for the therapy of multiple sclerosis[J].J Neuroimmunol,2005,159:155-164.
  • 9Monsiváis-Urenda AE,Baranda L,Alvarez-Quiroga C,et al.Expression and functional role of HLA-G in immune cells from patients with systemic lupus erythematosus[J].J Clin Immunol,2011,31:369-378.
  • 10Rebmann V,Busemann A,Lindemann M,et al.Detection of HLA-G5 secreting cells[J].Hum Immunol,2003,64:1017-1024.

二级参考文献26

  • 1Carosella ED, Moreau P, Maoult JL, et al. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol, 2003, 81: 199-252.
  • 2Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for the factors of HLA system. Tissue Antigens, 2002, 60: 407- 446.
  • 3Discorde ML, Moreau P, Sabatier P, et al. Expression of HLA-G in human cornea, an immune-prlvileged tissue. Hum Immunol, 2003, 64: 39-,~4.
  • 4Ito T, Ito N, Saathoff M, et al. Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol, 2005, 125:1139-1148.
  • 5Pistoia V, Morandi F, Wang XH, et al. Soluble HLA-G: are they clinically relevant. Semin Cancer Biol, 2007, 17: 469-479.
  • 6Carosella ED, Moreau P, LeMaoult J, et al. HLA-G: from biolo- gy to clinical benefitS. Trends Immunol, 2008, 29: 125-32.
  • 7Gotherstrom C, West A, Liden J, et al. Difference in gene ex- pression between human fetal liver and adult bone marrow mes- enchymal stem cells. Haematologica, 2005, 90: 1017-1026.
  • 8Park B, Lee S, Kim E, et al. The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compater- ments. Immunity, 2001, 15: 213-234.
  • 9Liang Sy, Ristich V, Arase H, et al. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway. Proc Natl Acad Sci USA, 2008, 105(24): 8357-8362.
  • 10LeMaoult J, Zafaranloo K, Le Danff C, et al. HLA-G up-regu- lates ILT2,ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK eells, and T cells. FASEB J, 2005, 19: 662-664.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部